VC  Flagship Pioneering

http://flagshippioneering.com





     Office Locations:

55 Cambridge Parkway, Suite 800E
Cambridge, MA 02142
Phone: 617-868-1888
Fax: 617-868-1115

 

Stages:

  • Early
  • Seed


 

Industries:

  • Energy & Clean Tech
  • Food & Agriculture
  • Life Sciences & Healthcare

  •  

    Description:

    Founded in 2000, Flagship Pioneering (f/k/a Flagship Ventures) is an entrepreneurship and venture capital firm based in Cambridge, MA. The Flagship investment team consists of 10 professionals focused on creating, financing, and building companies in the Therapeutics, Life Science & Diagnostics, and BioEnergy/Cleantech sectors. Flagship has funded more than 100 scientific ventures, resulting in $20 billion in aggregate value. Flagship's initial investment may range between $500,000 and $5 million. The firm may invest up to a total $7-$15 million during the life of an early stage venture and typically forms a syndicate that includes other leading venture firms. The firm announced in March of 2015 that it raised $537 million for Flagship Ventures Fund V, its largest fund since its founding in 2000. The new investment brought Flagship's aggregate funds under management to $1.4 billion at the time.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Chuck Carelli Chief Financial Officer
    David Epstein Executive Partner
    Doug Cole Managing Partner
    Erica Weinstein Senior Associate
    Ewen Cameron Senior Associate

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      03/14/2018


      Foghorn Therapeutics


      MA


      $50,000,000


      


      10/05/2017


      Visterra


      MA


      $46,700,000


      Series C


     

    Portfolio companies include:


      Accuri Cytometers
        web link


      Advanced Electron Beams
        web link


      Agios
        web link


      Ataris Biomedical
        web link


      Avedro
        web link


      Black Duck Software
        web link


      Blend Therapeutics
        web link


      Boragen


      Breathable Foods
        web link


      Celexion
        web link


      Codiak Biosciences
        web link


      Denali Therapeutics
        web link


      Editas Medicine
        web link


      Eleven
        web link


      Essentient
        web link


      Evelo Therapeutics
        web link


      ExactCost
        web link


      Foghorn Therapeutics
        web link


      Helicos
        web link


      Indigo
        web link


      Intio
        web link


      Joule
        web link


      Joule Unlimited
        web link


      KSQ Therapeutics
        web link


      Midori
        web link


      Moderna Therapeutics
        web link


      Novomer
        web link


      Oasys
        web link


      Permeon
        web link


      Polatis
        web link


      Pronutria
        web link


      Pronutria Biosciences
        web link


      Quanterix
        web link


      Receptos
        web link


      Red Rock Biofuels
        web link


      Rubius Therapeutics
        web link


      Seahorse Bioscience
        web link


      Selecta
        web link


      Selventa
        web link


      Seres Health
        web link


      Seventh Sense Biosystems
        web link


      Symbiota
        web link


      Syros Pharmaceuticals
        web link


      T2 Biosystems
        web link


      TARIS Biomedical
        web link


      TheraCrine
        web link


      TransMedics
        web link


      Visterra
        web link


      WikiCell Designs
        web link


     

    Recent News: